Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion

被引:29
作者
Périchon, R
Moser, AB
Wallace, WC
Cunningham, SC
Roth, GS
Moser, HW
机构
[1] NIA, Cellular & Mol Biol Lab, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA
[2] Kennedy Krieger Inst, Neurogenet Sect, Lab Peroxisomal Dis, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
peroxisome; plasmalogen; amyloid precursor protein; signal transduction; muscarinic cholinergic receptor;
D O I
10.1006/bbrc.1998.8909
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We tested whether alterations in membrane lipid composition associated with peroxisomal diseases affect muscarinic cholinergic signal transduction activity and amyloid precursor protein (APP) secretion in cultured human skin fibroblasts and Chinese hamster ovary (CHO) mutants. We found that in cell lines from patients with peroxisomal disorders where plasmalogen levels were low, the low-Km GTPase activity was not induced by carbachol, and APP secretion was reduced. This effect on signal transduction activity was not associated with decreased levels of the M1-muscarinic cholinergic receptor or its associated heterotrimeric G-protein. Specifically, this decrease was associated with a plasmalogen deficiency since a CHO cell line with only a deficit in plasmalogens was as severely affected as were generalized peroxisomal disorder cell lines, Thus, plasmalogens appear to be implicated in muscarinic cholinergic signal transduction and secretion of APP. These results provide new insights about the pathophysiology of peroxisomal diseases and may be relevant to Alzheimer's disease where reduced plasmalogen levels have been reported. (C) 1998 Academic Press.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 31 条
[1]   Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata [J].
Braverman, N ;
Steel, G ;
Obie, C ;
Moser, A ;
Moser, H ;
Gould, SJ ;
Valle, D .
NATURE GENETICS, 1997, 15 (04) :369-376
[2]  
CHECLER F, 1995, J NEUROCHEM, V65, P1431
[3]   A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY OF TACRINE FOR ALZHEIMERS-DISEASE [J].
DAVIS, KL ;
THAL, LJ ;
GAMZU, ER ;
DAVIS, CS ;
WOOLSON, RF ;
GRACON, SI ;
DRACHMAN, DA ;
SCHNEIDER, LS ;
WHITEHOUSE, PJ ;
HOOVER, TM ;
MORRIS, JC ;
KAWAS, CH ;
KNOPMAN, DS ;
EARL, NL ;
KUMAR, V ;
DOODY, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (18) :1253-1259
[4]   Plasmalogens, phospholipases A(2), and signal transduction [J].
Farooqui, AA ;
Yang, HC ;
Horrocks, LA .
BRAIN RESEARCH REVIEWS, 1995, 21 (02) :152-161
[5]   DISEASE AND ANATOMIC SPECIFICITY OF ETHANOLAMINE PLASMALOGEN DEFICIENCY IN ALZHEIMERS-DISEASE BRAIN [J].
GINSBERG, L ;
RAFIQUE, S ;
XUEREB, JH ;
RAPOPORT, SI ;
GERSHFELD, NL .
BRAIN RESEARCH, 1995, 698 (1-2) :223-226
[6]   PLASMENYLETHANOLAMINE FACILITATES RAPID MEMBRANE-FUSION - A STOPPED-FLOW KINETIC INVESTIGATION CORRELATING THE PROPENSITY OF A MAJOR PLASMA-MEMBRANE CONSTITUENT TO ADOPT AN H-II PHASE WITH ITS ABILITY TO PROMOTE MEMBRANE-FUSION [J].
GLASER, PE ;
GROSS, RW .
BIOCHEMISTRY, 1994, 33 (19) :5805-5812
[7]   GLYCEROLIPID BIOSYNTHESIS IN PEROXISOMES VIA THE ACYL DIHYDROXYACETONE PHOSPHATE-PATHWAY [J].
HAJRA, AK ;
BISHOP, JE .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 386 (MAY) :170-182
[8]   PLATELET-ACTIVATING-FACTOR - A BIOLOGICALLY-ACTIVE PHOSPHOGLYCERIDE [J].
HANAHAN, DJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 1986, 55 :483-509
[9]   MILLER-DIEKER LISSENCEPHALY GENE ENCODES A SUBUNIT OF BRAIN PLATELET-ACTIVATING-FACTOR [J].
HATTORI, M ;
ADACHI, H ;
TSUJIMOTO, M ;
ARAI, H ;
INOUE, K .
NATURE, 1994, 370 (6486) :216-218
[10]  
HUANG HM, 1994, ANN NY ACAD SCI, V747, P225